<code id='88D759F624'></code><style id='88D759F624'></style>

<acronym id='88D759F624'></acronym>

<center id='88D759F624'><center id='88D759F624'><tfoot id='88D759F624'></tfoot></center><abbr id='88D759F624'><dir id='88D759F624'><tfoot id='88D759F624'></tfoot><noframes id='88D759F624'>

<optgroup id='88D759F624'><strike id='88D759F624'><sup id='88D759F624'></sup></strike><code id='88D759F624'></code></optgroup>

<b id='88D759F624'><label id='88D759F624'><select id='88D759F624'><dt id='88D759F624'><span id='88D759F624'></span></dt></select></label></b><u id='88D759F624'></u>

~~<i id='88D759F624'><strike id='88D759F624'><tt id='88D759F624'><pre id='88D759F624'></pre></tt></strike></i>~~

hotspot

author hotspot

2025-09-29 05:37:38

Alexis Borisy — Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

advertisement

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Software glitch causes Tandem insulin pump to shutdown, FDA warns
Next article： Medical records are filled with copy

Tags

Leave your comment

fashion

Researchers on aging grapple with how to calculate biological age

fashion

ChatGPT in medicine: STAT answers readers' burning questions

2025-09-29 05:11

Use wet bulb globe temperature, not heat index, to protect workers

fashion

Apple is now the first public company to be valued at $3 trillion

2025-09-29 05:03

FDA panel endorses Alnylam’s heart drug — after picking it apart

comprehensive

Medical records are filled with copy

2025-09-29 05:34